Try our Advanced Search for more refined results
November 14, 2011
IN RE: Abbott-Depakote Shareholder Derivative Litigation
Case Number:
1:11-cv-08114
Court:
Nature of Suit:
160(Contract: Stockholders Suits)
Multi Party Litigation:
Derivative Litigation
Judge:
Firms
- Anderson & Wanca
- Freed Kanner
- Hagens Berman
- Jones Day
- Kessler Topaz
- Kirkland & Ellis
- Robbins Geller
- Shaw Fishman
- Spector Roseman
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
March 07, 2014
Abbott, Shareholders Agree To Settle Depakote Marketing Suit
Abbott Laboratories shareholders asked an Illinois federal judge on Thursday to bless a settlement resolving a derivative suit that alleged Abbott's directors cost the company $1.6 billion because they did nothing to stop the marketing of its anti-seizure drug Depakote for off-label uses.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login